B-cell receptor-guided delivery of peptide-siRNA complex for B-cell lymphoma therapy.

about

Impairment of T cell development and acute inflammatory response in HIV-1 Tat transgenic mice Peptide-guided targeting of GPR55 for anti-cancer therapy.Nanoparticle-based strategy for personalized B-cell lymphoma therapy.

P2860

Q36032171-3D7882FC-6756-4209-8A69-5DCC4C4CD63E Q36234465-276F1734-091C-4237-A524-40310A83193D Q37426956-AB8C712F-0660-4E8F-8A3A-9F168BDD2AA4

P2860

B-cell receptor-guided delivery of peptide-siRNA complex for B-cell lymphoma therapy.

Item

http://www.wikidata.org/entity/Q40706746

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

B-cell receptor-guided delivery of peptide-siRNA complex for B-cell lymphoma therapy.

@en

type

Item

label

B-cell receptor-guided delivery of peptide-siRNA complex for B-cell lymphoma therapy.

@en

prefLabel

B-cell receptor-guided delivery of peptide-siRNA complex for B-cell lymphoma therapy.

@en

P1476

B-cell receptor-guided delivery of peptide-siRNA complex for B-cell lymphoma therapy

@en

P2093

Annalisa Lamberti

http://www.w3.org/2001/XMLSchema#string

Giuseppe Scala

http://www.w3.org/2001/XMLSchema#string

Ileana Quinto

http://www.w3.org/2001/XMLSchema#string

Immacolata Ruggiero

http://www.w3.org/2001/XMLSchema#string

Iris Scala

http://www.w3.org/2001/XMLSchema#string

Nicola M Martucci

http://www.w3.org/2001/XMLSchema#string

Nunzia Migliaccio

http://www.w3.org/2001/XMLSchema#string

Paolo Arcari

http://www.w3.org/2001/XMLSchema#string

P2860

Protein measurement with the Folin phenol reagent

Nanocarriers as an emerging platform for cancer therapy

Reprogramming cell death: BCL2 family inhibition in hematological malignancies.

In vivo targeting and growth inhibition of the A20 murine B-cell lymphoma by an idiotype-specific peptide binder.

Delivery of siRNA therapeutics: barriers and carriers.

siRNAs: applications in functional genomics and potential as therapeutics.

Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs.

Eukaryotic Initiation Factor 4H Is under Transcriptional Control of p65/NF-κB.

In vivo activity of miR-34a mimics delivered by stable nucleic acid lipid particles (SNALPs) against multiple myeloma

Development of ligand-targeted liposomes for cancer therapy.

P2888

s12935-015-0202-4

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12935-015-0202-4

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Camillo Palmieri

Giuseppe Fiume

P577

2015-05-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276284152

http://www.w3.org/2001/XMLSchema#string

P6179

1017516163

http://www.w3.org/2001/XMLSchema#string

P698

25983658

http://www.w3.org/2001/XMLSchema#string

P932

4433068

http://www.w3.org/2001/XMLSchema#string

B-cell receptor-guided delivery of peptide-siRNA complex for B-cell lymphoma therapy.

about

P2860

P2860

B-cell receptor-guided delivery of peptide-siRNA complex for B-cell lymphoma therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P5875

P6179

P698

P932